Does CMV facilitate the recurrence of hepatitis C after transplantation? Małgorzata Pawłowska, Waldemar Halota Medical Science Review - Hepatologia 2005; 5 106-108 aaICID: 16123
IC™ Value: 1.86
Abstract provided by Publisher
Katedra i Klinika Chorób Zakaźnych i Hepatologii Collegium Medicum, Uniwersytetu Mikołaja Kopernika w Toruniu
Hepatitis C- associated liver failure is the most common indication for liver transplantation. The HCV infection recurs nearly universally after transplantation, up to 30% HCV-infected recipients develop liver cirrhosis within 5 years. Several post-liver transplant clinical factors seem to play a role in the severity of HCV recurrence and in overall patient and graft survival. CMV is associated with increased severity of HCV recurrence. Prophylaxis against CMV might reduce the impact of this infection on posttransplant outcome in HCV-infected liver transplant recipients.